UNSPSC 51282307: Lexithromycin

This classification denotes a macrolide antibiotic with the molecular formula C38H70N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7QKO29734U, chemically known as erythromycin, 9-(o-methyloxime) but generally known as lexithromycin, which bears US NIH Compound Identifier 9570610. European Medicines Agency schedules Lexithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08499MIG.

UNSPSC 51282307 Lexithromycin is a Commodity code covering a specific antibiotic pharmaceutical product, yet the recent state and local opportunities tagged under it show minimal direct purchasing activity for lexithromycin itself. Instead, the solicitations reflect broader pharmaceutical procurement through piggyback and direct-purchase mechanisms—including antibiotic medications like doxycycline and ciprofloxacin, as well as public-health supplies such as naloxone and drug deactivation systems. State and local issuers acquiring under this code include state health departments and county public-health authorities pursuing pharmaceutical stockpiles and emergency medical supplies through cooperative purchasing vehicles (such as MMCAP Infuse consortiums) and competitive sealed bids.

The Illinois Department of Public Health executed a piggyback pharmaceutical-warehouse award through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over a 12-month initial term with two optional renewal years, supplying doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets in 20-count packages. Seminole County, Florida issued an IFB on June 30, 2026 (response deadline July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a two-year contract term plus one-year renewal option. Recent activity concentrates in Florida and Illinois; the mismatch between the code name (lexithromycin) and the actual pharmaceutical products being procured suggests either miscoding by the issuing bodies or that this Commodity code functions as a catch-all for antibiotic and emergency-pharmaceutical procurement by state and local health agencies.